Parametric Portfolio Associates’s AbCellera Biologics ABCL Stock Holding History

Parametric Portfolio Associates’s Portfolio ABCL Stock Details ABCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$11.2M	Sell	1,150,000 -850,000	-43%	-$8.05M	0.01%	1287
2021 Q4	$28.6M	Buy	2,000,000 +300,000	+18%	+$4.55M	0.01%	770
2021 Q3	$34.1M	Buy	1,700,000 +200,000	+13%	+$3.54M	0.02%	691
2021 Q2	$33M	Buy	+1,500,000	New	+$41.4M	0.02%	728

Other funds holding ABCL

Capital World Investors

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Allianz Asset Management

Allianz Asset Management Munich, Germany $86.6B AUM 38.74% 1-Year Est. Return

Baillie Gifford & Co

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

SB Management Abu Dhabi, United Arab Emirates $512M AUM 40.71% 1-Year Est. Return

DCVC Bio Palo Alto, California $313K AUM

OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return

Harvard Management Company Boston, Massachusetts $1.82B AUM 26.23% 1-Year Est. Return

Founders Fund VII Management San Francisco, California $2.03M AUM 72.34% 1-Year Est. Return

Guardian Capital Advisors (Canada) Toronto, Ontario, Canada $1.02B AUM 25.29% 1-Year Est. Return